InformationMito-TEMPO Mito-TEMPO (MT), a mitochondria-targeted superoxide dismutase mimetic, protects against the early phase of acetaminophen (APAP) hepatotoxicity by inhibiting peroxynitrite formation. Mito-TEMPO treatment inhibits APAP-induced RIP3 kinase expression.TargetsRIP3 kinaseIn vitroMito-TEMPO improves blastocyst development by superoxide reduction in porcine embryos in vitro.In vivoMito-Tempo (MT) treatment inhibits APAP-induced RIP3 kinase expression, and RIP3-deficient mice shows caspase activation and apoptotic morphology in hepatocytes analogous to MT treatment.Cell Research(from reference)Cell lines:Porcine embryos Concentrations:0.1/u2009μM.
Specifications and Purity: 10mM in DMSO
Molecular Formula: C29H36ClN2O2P
Molecular Weight: 511
PubChem CID: 134828258
- UPC:
- 12141803
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- M421267-1ml
- CAS:
- 1334850-99-5
- Product Size:
- 1ml
akash.verma@cenmed.com
(732) 447-1115





